knowledge -WSS

knowledge

author：hotspot 2025-10-01 21:35:51 - browse：1

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： HIV drugs protect against transmission, even in unprotected sex

hotspot

WSS

Telehealth for opioid use disorder is lifesaving

FDA panel endorses Alnylam’s heart drug — after picking it apart

Change Healthcare can notify patients about the breach, HHS says

How medical schools plan to diversify without affirmative action

Letters to First Opinion on caregivers, digital health, and more

Shifting the focus from loneliness to social health

entertainment

knowledge

Wikipedia

How to save PrEP access — and even expand it

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

The cancer drug shortage isn’t new — and neither are the solutions

Pig kidney works a record two months in donated body

As demand for Covid shots wanes, Moderna seeks its next success

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Guidelines to prevent youth baseball injuries need more muscle

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Guidelines to prevent youth baseball injuries need more muscle

Walmart eyes Medicare Advantage provider ChenMed

hotspot

New Covid vaccine is recommended for everyone 6 months or older

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Hospitals consider fixing cancer drug shortages on their own

What to make of Biden’s latest efforts on cancer research

White House touts steps to stem shortages of cancer treatments

Private equity could exacerbate cardiology's overuse problem, experts fear

focus

hotspot

Wikipedia

entertainment